USPTO serial 79338857
CERBA RESEARCH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 6, 2024
- Examiner
- LOZEAU, BRANDON THOMAS
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CERBA RESEARCH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey A. Smith
Jeffrey A. Smith Millen, White, Zelano & Branigan, P.C.2200 Clarendon BoulevardSuite 1400Arlington, VA 22201Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Blood for medical purposes; biological tissue cultures for medical purposes; chemical reagents for medical use; diagnostic products for medical use, namely, medical diagnostic reagents and assays for testing of body fluids, medical diagnostic reagents; in vitro medical diagnostic testing kits comprised of reagents and assays of blood, tissue, biospecimens in the nature of serum, plasma, urine, that test for the presence of infertility, diseases, cancer; diagnostic reagents for medical or biological use sold in kit form | ACTIVE | — |
| 010 | Biological sampling collection kit for medical and diagnostic use comprised of swabs, CSF sampling tubes, holders for medical sample tubes and vials and medical specimen bags for holding body tissue samples, for testing blood, tissue, biospecimens in the nature of serum, plasma, and urine; biological sampling kit for use in clinical trials comprised of swabs, CSF sampling tubes, holders for medical sample tubes and vials and medical specimen bags for holding body tissue samples, for testing blood, tissue, biospecimens in the nature of serum, plasma, and urine; biological sampling kit for medical and biological screening use comprised of swabs, CSF sampling tubes, holders for medical sample tubes and vials and medical specimen bags for holding body tissue samples, for testing blood, tissue, biospecimens in the nature of serum, plasma, and urine; apparatus for medical use for detecting microorganisms, bacteria, yeast, viruses; apparatus for medical use in analyzing biological samples | ACTIVE | — |
| 042 | Scientific advisory services with respect to monitoring medical diagnostic protocols; scientific advisory services with respect to calibrating scientific apparatus and instruments; scientific advisory services with respect to calibrating diagnostic apparatus and instruments; scientific advisory services with respect to developing chemical and biological reagents; laboratory services, namely, preparation of biological samples for research purposes; laboratory services, namely, preparation of biological samples for testing and analysis in research laboratories; scientific and technological services, namely, scientific research, analysis, testing in the field of genetics and medical diagnostics; scientific laboratory services; medical laboratory services; laboratory services in medical biology, namely, chemical analyses, biological analyses, bacteriological analyses, biochemical analyses, genetic analyses; medical, veterinary, pharmacological, agri-food, cosmetic research services; biological and medical research; clinical research in the field of genetics and medical diagnostics; biological, pharmacological and genetic analyses for scientific and medical research purposes; participation in conducting clinical trials, namely, scientific research in the nature of conducting clinical trials for others; providing information and data with respect to research and development in the medical, biological, pharmaceutical, agri-food, cosmetic and veterinary fields; providing information concerning the development, monitoring and results of clinical trials; engineering services in the medical field of public human health; research services in the field of human medical biology; biological and pharmaceutical research; quality control for others; designing and developing software for use as a database and medical record keeping, particularly in the medical field of human health; designing and developing databases, particularly in the medical field of human health; scientific advisory services, namely, providing advice on aspects relating to medical biology and anatomical-cytopathology examinations necessary for conducting clinical trials; scientific advisory services, namely, providing advice on clinical trial protocols; veterinary laboratory services; engineering and research services for others, namely, scientific research in the field of genetics, genetic testing and research and development of computer software; designing and developing software for accessing and viewing medical testing results and biological testing results; designing and developing databases; non-medical, ultrasound imaging services | ACTIVE | — |
| 044 | Blood bank services; biological sampling bank services, namely, organ and tissue bank services; biological sampling collection services being medical services; providing medical information, namely, compilation of medical reports; medical biology laboratory services, namely, medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical laboratory services for the analysis of samples taken from patients being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical, biological and veterinary analysis services for the diagnosis and treatment of humans and animals; medical, biological and veterinary information services, namely, providing information relating to treatment and management of diseases or conditions for humans and animals; medical advisory services relating to clinical trial issues; medical, biological and veterinary information retrieval service in the nature of medical information provided to medical professionals from remote locations via the Internet and global computer networks through the use of archived medical images and a data storage and retrieval system; medical testing for diagnostic purposes in the context of clinical trials; advisory services in the field of medical public health; provision of medical information in the field of health; providing medical information to patients, namely, provision of individual medical examination reports; carrying out disease diagnoses, namely, medical diagnosis of infertility, infectious diseases and cancer; medical and biological consultancy in the field of genetic testing, in vitro fertilization, and medical, biological and veterinary analysis services for the diagnosis and treatment of humans and animals; medical and biological analyses for treating people; veterinary and biological analyses for treating animals; DNA analyses for medical and veterinary purposes; genetic analyses for medical and veterinary use; medical and veterinary screening; medical imaging services; medical, biological and veterinary diagnostic services; services for preparing medical reports, namely, providing medical information to customers and medical professionals in the form of reports in the field of infertility, infectious diseases and cancer; medical and health assessment services with respect to DNA, genetics and genetic testing; medical testing for diagnostic or treatment purposes; x-ray examinations for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CERBA HEALTHCARE
- Other trademarks owned by CERBA HEALTHCARE
- Other trademarks owned by CERBA HEALTHCARE
- Other trademarks owned by CERBA HEALTHCARE
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CERBA RESEARCH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 23, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 15, 2024 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jun 2, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 10, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 10, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 6, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 6, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 6, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 21, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 21, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 21, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 1, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 1, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 1, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 20, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 17, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 17, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 17, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 17, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 16, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 16, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 16, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 16, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 16, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 27, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 27, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 20, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 20, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 20, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 20, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 20, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 19, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 19, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 7, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 19, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 19, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 11, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 10, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 8, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| May 10, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 5, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 2, 2022 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Apr 21, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |